However, the Brazilian Society of Rheumatology consensus guidelines for the diagnosis, management and treatment of LN in adult SLE have also concluded that “ARBs and ACE inhibitors should be used as antiproteinuric agents unless contraindicated” (69). Here, ACE is linked to systemic lupus erythematosus.